Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Britt-Marie Zetterqvist"'
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 87:1343-1352
To evaluate long-term survival and prognostic factors for all epithelial ovarian cancer (EOC) patients after adjuvant treatment with paclitaxel and carboplatin.Prospectively collected data from a population-based cohort.Western Sweden Health Care Reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43ed29fd282ae12b608c40fd9c13eca8
https://doi.org/10.1080/00016340802495491
https://doi.org/10.1080/00016340802495491
Autor:
Britt-Marie Zetterqvist, György Horvath, Margaretha Åkeson, Kristina Levan, Karolina Partheen, Mats Brännström, Lovisa Österberg
Publikováno v:
Cancer Genetics and Cytogenetics. 167:103-108
Borderline tumors of the ovary comprise 10-20% of all epithelial ovarian tumors, and are placed between clearly benign and obviously malignant ovarian tumors. The issue of whether borderline tumors are precursors of invasive carcinoma or distinct cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::700d666dae9d3329e86350266f834cc9
https://doi.org/10.1016/j.cancergencyto.2006.01.009
https://doi.org/10.1016/j.cancergencyto.2006.01.009
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 84:1113-1118
Background. New clinical guidelines (CGs) for ovarian cancer in the western health care region in Sweden were established, beginning in September 1993 and still in effect. Methods. A retrospective evaluation of 5 years of quality registration linked
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58fb8034a0a1df0a503123dbbe12ac5f
https://doi.org/10.1111/j.0001-6349.2005.00850.x
https://doi.org/10.1111/j.0001-6349.2005.00850.x
Autor:
Britt-Marie Zetterqvist, Erik Holmberg, Anne-Marie Jakobsen, György Horvath, Mats Brännström, Margaretha Åkeson
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 19(1)
Epithelial ovarian cancer (EOC) is the major gynecologic cancer mortality cause in Sweden. The aim of the present study was to investigate the long-term survival and prognostic factors of a complete population-based 5-year cohort of 682 patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0baa283b1e64325b10631f8f61bcd20
https://pubmed.ncbi.nlm.nih.gov/19258952
https://pubmed.ncbi.nlm.nih.gov/19258952
Autor:
Anne-Marie Jakobsen, Mats Brännström, György Horvath, K. Dahllöf, Margaretha Åkeson, Britt-Marie Zetterqvist
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 18(3)
Borderline ovarian tumors (BOTs) make up around 10–20% of all epithelial ovarian tumors. The aim of the present study was to investigate the outcome of a complete large population-based cohort of patients treated for BOT. All patients (n= 399) trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9586a5750adb712c2ed9ba87b5cd5450
https://pubmed.ncbi.nlm.nih.gov/18476948
https://pubmed.ncbi.nlm.nih.gov/18476948
Publikováno v:
Acta obstetricia et gynecologica Scandinavica. 84(11)
New clinical guidelines (CGs) for ovarian cancer in the western health care region in Sweden were established, beginning in September 1993 and still in effect.A retrospective evaluation of 5 years of quality registration linked to CGs for ovarian can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::12f4a8b3f17ccb9ee578c2d9cf2dfe26
https://pubmed.ncbi.nlm.nih.gov/16232182
https://pubmed.ncbi.nlm.nih.gov/16232182